Alexandra J Kent
Overview
Explore the profile of Alexandra J Kent including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
216
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Noor N, Lee J, Bond S, Dowling F, Brezina B, Patel K, et al.
Lancet Gastroenterol Hepatol
. 2024 Feb;
9(5):415-427.
PMID: 38402895
Background: Management strategies and clinical outcomes vary substantially in patients newly diagnosed with Crohn's disease. We evaluated the use of a putative prognostic biomarker to guide therapy by assessing outcomes...
2.
Liu Z, Alexander J, Yee Eng K, Ibraheim H, Anandabaskaran S, Saifuddin A, et al.
J Crohns Colitis
. 2023 Nov;
18(4):560-569.
PMID: 37941436
Background And Aims: We sought to determine whether six commonly used immunosuppressive regimens were associated with lower antibody responses after seasonal influenza vaccination in patients with inflammatory bowel disease [IBD]....
3.
Liu Z, Alexander J, Le K, Zhou X, Ibraheim H, Anandabaskaran S, et al.
EClinicalMedicine
. 2023 Oct;
64:102249.
PMID: 37842172
Background: Patients with inflammatory bowel disease (IBD) receiving anti-TNF and JAK-inhibitor therapy have attenuated responses to COVID-19 vaccination. We aimed to determine how IBD treatments affect neutralising antibody responses against...
4.
Saifuddin A, Kent A, Mehta S, Sebastian S
Aliment Pharmacol Ther
. 2022 Dec;
57(1):156-157.
PMID: 36468219
No abstract available.
5.
Saifuddin A, Kent A, Mehta S, Hicks L, Gonzalez H, Segal J, et al.
Aliment Pharmacol Ther
. 2022 Oct;
56(10):1460-1474.
PMID: 36196569
Background: The COVID-19 pandemic offered a unique opportunity to understand inflammatory bowel disease (IBD) management during unexpected disruption. This could help to guide practice overall. Aims: To compare prescribing behaviour...
6.
Alexander J, Liu Z, Munoz Sandoval D, Reynolds C, Ibraheim H, Anandabaskaran S, et al.
Lancet Gastroenterol Hepatol
. 2022 Sep;
7(11):1005-1015.
PMID: 36088954
Background: COVID-19 vaccine-induced antibody responses are reduced in patients with inflammatory bowel disease (IBD) taking anti-TNF or tofacitinib after two vaccine doses. We sought to assess whether immunosuppressive treatments were...
7.
Nayagam J, Mandour M, Taylor A, Heneghan M, Dubois P, Hayee B, et al.
Clin Res Hepatol Gastroenterol
. 2022 Jun;
46(7):101980.
PMID: 35728760
Background & Aims: Autoimmune sclerosing cholangitis (ASC) is a childhood sclerosing cholangitis frequently associated with inflammatory bowel disease (IBD). We describe the IBD phenotype in ASC patients and associated liver...
8.
Alexander J, Kennedy N, Ibraheim H, Anandabaskaran S, Saifuddin A, Castro Seoane R, et al.
Lancet Gastroenterol Hepatol
. 2022 Feb;
7(4):342-352.
PMID: 35123676
Background: The effects that therapies for inflammatory bowel disease (IBD) have on immune responses to SARS-CoV-2 vaccination are not yet fully known. Therefore, we sought to determine whether COVID-19 vaccine-induced...
9.
Sebastian S, Patel K, Segal J, Subramanian S, Conley T, Gonzalez H, et al.
BMJ Open Gastroenterol
. 2022 Feb;
9(1).
PMID: 35101886
Introduction: Acute severe ulcerative colitis (ASUC) traditionally requires inpatient hospital management for intravenous therapies and/or colectomy. Ambulatory ASUC care has not yet been evaluated in large cohorts. Aims: We used...
10.
Mateen B, Samanta S, Tullie S, ONeill S, Cargill Z, Kelly G, et al.
BMJ Open Gastroenterol
. 2021 Sep;
8(1).
PMID: 34489301
Objective: The aims of this study were to describe community antibiotic prescribing patterns in individuals hospitalised with COVID-19, and to determine the association between experiencing diarrhoea, stratified by preadmission exposure...